The Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market size is expected to grow at an annual average of 8% during 2022-2028. Alpha1-antitrypsin deficiency (AATD) is a genetic disorder characterized by low or unpredictable levels of alpha-1 protein produced by the liver. The disease most commonly affects the lungs and liver and is often undiagnosed. Augmentation therapy […]
